Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Johnson & Johnson (JNJ): Hedge Funds Are Bullish On This Trending AI Stock Right Now

We recently compiled a list of the 10 Trending AI Health Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other AI health stocks.

According to Statista Market Insights, the worldwide artificial intelligence (AI) market is projected to reach a size of $184 billion in 2024. With a compound annual growth rate (CAGR) of 28.46% between 2024 and 2030, the market is expected to expand significantly, reaching a total value of $826.70 billion by 2030. In a global comparison, the United States is set to dominate with the largest market size, valued at $50.16 billion in 2024, leading the adoption and innovation in AI technology.

The global AI healthcare market is experiencing rapid expansion as well, driven by advancements in machine learning, automation, and precision medicine. With a market size of around $15.4 billion in 2022, it is projected to grow at a compound annual growth rate (CAGR) of 37.5%, reaching over $187 billion by 2030, according to estimates by Grand View Research. This growth is largely fueled by the increased adoption of AI in diagnostics, drug discovery, robotic surgery, and patient monitoring, as healthcare systems seek more efficient and cost-effective solutions.

Read more about these developments by accessing 33 Most Important AI Companies You Should Pay Attention To and 20 Industrial Stocks Already Riding the AI Wave.

Reputable sources such as Fortune Business Insights and McKinsey report similar bullish projections, highlighting that AI’s applications in healthcare are expanding from diagnostics and imaging to personalized medicine and surgery. The FDA’s approval of numerous AI-driven tools in recent years underlines this shift. As AI permeates every level of healthcare, the demand for AI-enhanced devices and platforms continues to surge, resulting in massive investments, partnerships, and growing startup valuations, especially in medical imaging and AI-powered therapeutics.

According to Eric Topol, a renowned cardiologist and AI expert, AI is reshaping healthcare by enhancing precision in diagnostics and treatment. In his book “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again,” Topol argues that AI not only boosts efficiency but also provides better patient outcomes through personalized medicine and improved medical imaging. He states, “AI has the potential to restore the human connection in medicine by allowing doctors more time to focus on their patients, while AI handles data analysis and routine tasks.” Topol envisions that AI will reduce physician burnout and transform healthcare delivery globally.

Read more about these developments by accessing 30 Most Important AI Stocks According to BlackRock and AI News You Should Not Have Missed.

Our Methodology

For this article, we selected trending health stocks that have AI products driving meaningful revenue gains. These stocks are also popular among hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A smiling baby with an array of baby care products in the foreground.

Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 80

Johnson & Johnson (NYSE:JNJ) has integrated AI into its MedTech and pharmaceutical divisions, particularly in surgical robotics and drug discovery. Ethicon, a subsidiary of J&J, uses AI in surgical planning and execution, improving precision and patient outcomes. AI tools are also aiding J&J in advancing drug discovery, particularly in oncology and immunology, where AI accelerates the identification of new therapies.

Financially, AI-driven innovations have positively impacted J&J’s performance. In 2023, the company’s total sales rose to $85.2 billion, a 6.5% year-over-year increase. The MedTech segment grew by 12.4%, reflecting strong demand for AI-enhanced surgical tools. In 2024, Johnson & Johnson (NYSE:JNJ) expects revenues between $89.2 billion and $89.6 billion, driven by growth in its MedTech and Innovative Medicine segments, which benefit from AI advancements in surgery and drug development.

Overall JNJ ranks 3rd on our list of the trending AI stocks. While we acknowledge the potential of JNJ as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than JNJ but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article is originally published at Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!